
Why immunotherapy still holds so much potential
Dr Jill O’Donnell Tormey, CEO and Director of Scientific Affairs at the Cancer Research Institute, US, discusses the future of cancer research with DDW’s Megan Thomas. Innovation & opportunity Reflecting on innovation and opportunity in global cancer research, Dr Jill O’Donnell-Tormey recognises modalities like cell therapies, bispecifics, antibody drug conjugates… Read More















